Motavizumab

莫维珠单抗

CAS No: 677010-34-3

677010-34-3
67701-29-5 ANTIFOAM B
67701-23-9 Talloilacid,magnesium salt
67700-82-7 Linseed oil, polymer with pentaerythritol, phthalic anhydride and soybean oil
67703-99-5 Hexanedioic acid, polymer with N-(2-aminoethyl)-1,2-ethanediamine and 1,2-dichloroethane
82747-36-2 6,7-DIHYDROXY-4-(TRIFLUOROMETHYL)COUMARIN
67700-92-9 Fatty acids, tall-oil, polymers with pentaerythritol and phthalic anhydride
827-44-1 5-CHLORO-3-PHENYL-1,2,4-OXADIAZOLE
13224-40-3 p-Tetradecyloxyphenol
67701-20-6 SODIUM DILINOLEATE
677010-34-3 Motavizumab
21487-48-9 3-METHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE, 97%
132244-31-6 5-BROMO-BENZOOXAZOLE
67701-03-5 FATTY ACIDS C16-18
677-24-7 METHYL PHOSPHORODICHLORIDATE
67706-68-7 TERT-BUTYL 3-(ETHOXYCARBONYL)-2-OXOPROPYLCARBAMATE
62732-44-9 CBI-BB ZERO/005050
214902-82-6 Decladinose Roxithromycin (Roxithromycin Impurity B)
62728-88-5 RHODIUM(II) TRIMETHYLACETATE
132249-12-8 2-(2-AMINO-4-BIPHENYL)PROPIONITRILE
660425-16-1 2-Bromo-3,5-Fluoropyridine
677010-34-3 motavizumab,677010-34-3
2025-06-16 Discover Motavizumab (CAS No: 677010-34-3) and related compounds. Ideal for advanced chemical applications. Competitive pricing, fast delivery, and expert support worldwide.